The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Arginine Signaling and Cancer Metabolism
Open accessAbstract
Arginine is an amino acid critically involved in multiple cellular processes including the syntheses of nitric oxide and polyamines, and is a direct activator of mTOR, a nutrient-sensing kinase strongly implicated in carcinogenesis. Yet, it is also considered as a non- or semi-essential amino acid, due to normal cells’ intrinsic ability to synthesize arginine from citrulline and aspartate via ASS1 (argininosuccinate synthase 1) and ASL (argininosuccinate lyase). As such, arginine can be used as a dietary supplement and its depletion as a therapeutic strategy. Strikingly, in over 70% of tumors, ASS1 transcription is suppressed, rendering the cells addicted to external arginine, forming the basis of arginine-deprivation therapy. In this review, we will discuss arginine as a signaling metabolite, arginine’s role in cancer metabolism, arginine as an epigenetic regulator, arginine as an immunomodulator, and arginine as a therapeutic target. We will also provide a comprehensive summary of ADI (arginine deiminase)-based arginine-deprivation preclinical studies and an update of clinical trials for ADI and arginase. The different cell killing mechanisms associated with various cancer types will also be described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D. S., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,769
Amino acids: Metabolism, functions, and nutrition
Wu, G. (2009) · Amino Acids · doi:10.1007/s00726-009-0269-0 · Cited by 3,004
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Geiger, R., Rieckmann, J. C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.031 · Cited by 1,775
Wink, D. A., & Mitchell, J. B. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00092-6 · Cited by 1,606
Metabolic pathways promoting cancer cell survival and growth
Boroughs, L. K., & DeBerardinis, R. J. (2015) · Nature Cell Biology · doi:10.1038/ncb3124 · Cited by 1,462
DNA double-strand break repair-pathway choice in somatic mammalian cells
Scully, R., Panday, A., Elango, R., & Willis, N. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0152-0 · Cited by 1,457
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y.-L., & Schulze, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.007 · Cited by 1,413
Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages
Rath, M., Müller, I., Kropf, P., Closs, E. I., & Munder, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00532 · Cited by 1,262
The role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
Hsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., et al. (2011) · Science · doi:10.1126/science.1199498 · Cited by 1,084
Mitochondrial dysfunction prevents repolarization of inflammatory macrophages
Van den Bossche, J., Baardman, J., Otto, N. A., van der Velden, S., Neele, A. E., van den Berg, S. M., Luque-Martin, R., Chen, H.-J., Boshuizen, M. C. S., Ahmed, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.008 · Cited by 1,027
L-arginine availability regulates T-lymphocyte cell-cycle progression.
Rodriguez, P. C., Quiceno, D. G., & Ochoa, A. C. (2007) · Blood · doi:10.1182/blood-2006-06-031856 · Cited by 926
Amino acid signalling upstream of mTOR
Jewell, J. L., Russell, R. C., & Guan, K.-L. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3522 · Cited by 894
The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway
Chantranupong, L., Scaria, S. M., Saxton, R. A., Gygi, M. P., Shen, K., Wyant, G. A., Wang, T., Harper, J. W., Gygi, S. P., & Sabatini, D. M. (2016) · Cell · doi:10.1016/j.cell.2016.02.035 · Cited by 843 · cited 1×
“(3) in the cytosol, arginine interacts with CASTOR1(cytosolic arginine sensor for mTORC1 subunit 1) to disrupt the CASTOR complex, which is a negative regulator of Rag A [55], allowing Rag A to bind mTORC1 component RAPTOR (Regulatory-associated protein of mTOR) and redistributes mTORC1 to the lysosome.”
BackgroundLysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
Wang, S., Tsun, Z.-Y., Wolfson, R. L., Shen, K., Wyant, G. A., Plovanich, M. E., Yuan, E. D., Jones, T. D., Chantranupong, L., Comb, W., et al. (2015) · Science · doi:10.1126/science.1257132 · Cited by 824
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1
Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013) · Science · doi:10.1126/science.1228792 · Cited by 739
Nutrient sensing and TOR signaling in yeast and mammals
González, A., & Hall, M. N. (2017) · The EMBO Journal · doi:10.15252/embj.201696010 · Cited by 732
Functions of Polyamines in Mammals
Pegg, A. E. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.731661 · Cited by 718
Serafini, P., Mgebroff, S., Noonan, K., & Borrello, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6621 · Cited by 673
Role of nitric oxide in carcinogenesis and tumour progression
Lala, P. K., & Chakraborty, C. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00256-4 · Cited by 570
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 531
Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., Prescianotto-Baschong, C., Sauer, U., Jenoe, P., & Hall, M. N. (2013) · Science · doi:10.1126/science.1228771 · Cited by 525
Regulation of T Cell Receptor CD3ζ Chain Expression byl-Arginine
Rodriguez, P. C., Zea, A. H., Culotta, K. S., Zabaleta, J., Ochoa, J. B., & Ochoa, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110675200 · Cited by 509
l -Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes
Rodriguez, P. C., Zea, A. H., DeSalvo, J., Culotta, K. S., Zabaleta, J., Quiceno, D. G., Ochoa, J. B., & Ochoa, A. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1232 · Cited by 492
Steggerda, S. M., Bennett, M. K., Chen, J., Emberley, E., Huang, T., Janes, J. R., Li, W., MacKinnon, A. L., Makkouk, A., Marguier, G., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0308-4 · Cited by 476
Palmieri, E. M., Gonzalez-Cotto, M., Baseler, W. A., Davies, L. C., Ghesquière, B., Maio, N., Rice, C. M., Rouault, T. A., Cassel, T., Higashi, R. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14433-7 · Cited by 464
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441
Myeloid Cell-Derived Arginase in Cancer Immune Response
Grzywa, T. M., Sosnowska, A., Matryba, P., Rydzynska, Z., Jasinski, M., Nowis, D., & Golab, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00938 · Cited by 424
Nutrient signaling to mTOR and cell growth
Jewell, J. L., & Guan, K.-L. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.01.004 · Cited by 410
Mechanisms of the Antioxidant Effects of Nitric Oxide
Wink, D. A., Miranda, K. M., Espey, M. G., Pluta, R. M., Hewett, S. J., Colton, C., Vitek, M., Feelisch, M., & Grisham, M. B. (2001) · Antioxidants & Redox Signaling · doi:10.1089/152308601300185179 · Cited by 400
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
Hu, W., Wang, G., Huang, D., Sui, M., & Xu, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01205 · Cited by 398
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., et al. (2015) · Nature · doi:10.1038/nature15529 · Cited by 382 · cited 2×
“As described above, one possible explanation is that ASS1 diverts aspartate to arginine synthesis from pyrimidine/purine synthesis which is much needed for tumor cells [81].”
BackgroundGaude, E., & Frezza, C. (2016) · Nature Communications · doi:10.1038/ncomms13041 · Cited by 375
Autophagy maintains tumour growth through circulating arginine
Poillet-Perez, L., Xie, X., Zhan, L., Yang, Y., Sharp, D. W., Hu, Z. S., Su, X., Maganti, A., Jiang, C., Lu, W., et al. (2018) · Nature · doi:10.1038/s41586-018-0697-7 · Cited by 360
Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle
Husson, A., Brasse‐Lagnel, C., Fairand, A., Renouf, S., & Lavoinne, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03559.x · Cited by 328
Rewiring urea cycle metabolism in cancer to support anabolism
Keshet, R., Szlosarek, P., Carracedo, A., & Erez, A. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0054-z · Cited by 323
Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe, J., Jung, J. U., Gandour-Edwards, R., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 317
Self-citationEnsor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315
Isenberg, J. S., Martin-Manso, G., Maxhimer, J. B., & Roberts, D. D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2561 · Cited by 305
Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy
Wang, W., & Zou, W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.006 · Cited by 298
Arginine dependence of tumor cells: targeting a chink in cancer’s armor
Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C., & Fukumura, D. (2016) · Oncogene · doi:10.1038/onc.2016.37 · Cited by 265
Abou-Alfa, G. K., Qin, S., Ryoo, B.-Y., Lu, S.-N., Yen, C.-J., Feng, Y.-H., Lim, H. Y., Izzo, F., Colombo, M., Sarker, D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy101 · Cited by 237
Tsai, W.-B., Aiba, I., Long, Y., Lin, H.-K., Feun, L., Savaraj, N., & Kuo, M. T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3605 · Cited by 233
Rahman, M. A., Dhar, D. K., Yamaguchi, E., Maruyama, S., Sato, T., Hayashi, H., Ono, T., Yamanoi, A., Kohno, H., & Nagasue, N. (2001) · PubMed · Cited by 223
Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells
Qiu, F., Chen, Y.-R., Liu, X., Chu, C.-Y., Shen, L.-J., Xu, J., Gaur, S., Forman, H. J., Zhang, H., Zheng, S., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004761 · Cited by 217
Self-citationSzlosarek, P. W., Steele, J. P., Nolan, L., Gilligan, D., Taylor, P., Spicer, J., Lind, M., Mitra, S., Shamash, J., Phillips, M. M., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3049 · Cited by 201
Changou, C. A., Chen, Y.-R., Xing, L., Yen, Y., Chuang, F. Y. S., Cheng, R. H., Bold, R. J., Ann, D. K., & Kung, H.-J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404171111 · Cited by 189
Self-citationControl of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
Carroll, B., Maetzel, D., Maddocks, O. D., Otten, G., Ratcliff, M., Smith, G. R., Dunlop, E. A., Passos, J. F., Davies, O. R., Jaenisch, R., et al. (2016) · eLife · doi:10.7554/elife.11058 · Cited by 183
Szlosarek, P. W., Klabatsa, A., Pallaska, A., Sheaff, M., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P., Rudd, R. M., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Chalishazar, M. D., Wait, S. J., Huang, F., Ireland, A. S., Mukhopadhyay, A., Lee, Y., Schuman, S. S., Guthrie, M. R., Berrett, K. C., Vahrenkamp, J. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4140 · Cited by 174
Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice
Ambs, S., Ogunfusika, M. O., Merriam, W. G., Bennett, W. P., Billiar, T. R., & Harris, C. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8823 · Cited by 171
Syed, N., Langer, J., Janczar, K., Singh, P., Lo Nigro, C., Lattanzio, L., Coley, H. M., Hatzimichael, E., Bomalaski, J., Szlosarek, P., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2012.197 · Cited by 168
Qualls, J. E., Neale, G., Smith, A. M., Koo, M.-S., DeFreitas, A. A., Zhang, H., Kaplan, G., Watowich, S. S., & Murray, P. J. (2010) · Science Signaling · doi:10.1126/scisignal.2000955 · Cited by 167
Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction
Cheng, C.-T., Qi, Y., Wang, Y.-C., Chi, K. K., Chung, Y., Ouyang, C., Chen, Y.-R., Oh, M. E., Sheng, X., Tang, Y., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0178-4 · Cited by 167
Self-citationKong, X., Tan, B., Yin, Y., Gao, H., Li, X., Jaeger, L. A., Bazer, F. W., & Wu, G. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.06.012 · Cited by 166
Espey, M. G., Miranda, K. M., Thomas, D. D., Xavier, S., Citrin, D. E., Vitek, M. P., & Wink, D. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04068.x · Cited by 163
Huang, H.-Y., Wu, W.-R., Wang, Y.-H., Wang, J., Fang, F.-M., Tsai, J.-W., Li, S.-H., Hung, H.-C., Yu, S.-C., Lan, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2641 · Cited by 163
Kremer, J. C., Prudner, B. C., Lange, S. E. S., Bean, G. R., Schultze, M. B., Brashears, C. B., Radyk, M. D., Redlich, N., Tzeng, S.-C., Kami, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.077 · Cited by 159
Arginine and the metabolic regulation of nitric oxide synthesis in cancer
Keshet, R., & Erez, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033332 · Cited by 158
Arginine metabolism and deprivation in cancer therapy
Zou, S., Wang, X., Liu, P., Ke, C., & Xu, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109210 · Cited by 158
Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153
Self-citationTsai, W.-B., Aiba, I., Lee, S.-Y., Feun, L. G., Savaraj, N., & Kuo, M. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0794 · Cited by 148
Delage, B., Luong, P., Maharaj, L., Ó’Riain, C., Syed, N., Crook, T., Hatzimichael, E. C., Papoudou‐Bai, A., Mitchell, T. J., Whittaker, S. J., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.83 · Cited by 146
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B.-W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9862-2 · Cited by 146
Arginine and Leucine regulate p70 S6 kinase and 4E-BP1 in intestinal epithelial cells
Ban, H., Shigemitsu, K., Yamatsuji, T., Haisa, M., Nakajo, T., Takaoka, M., Nobuhisa, T., Gündüz, M., Tanaka, N., & Naomoto, Y. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.13.4.537 · Cited by 142
Gupta, N., Miyauchi, S., Martindale, R. G., Herdman, A. V., Podolsky, R. H., Miyake, K., Mager, S., Prasad, P. D., Ganapathy, M. E., & Ganapathy, V. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.04.002 · Cited by 142
Wong, C. C., Qian, Y., Li, X., Xu, J., Kang, W., TONG, J. H. M., To, K., Ye, J., Li, W., Chen, H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.011 · Cited by 138
Schleicher, U., Paduch, K., Debus, A., Obermeyer, S., König, T., Kling, J. C., Ribechini, E., Dudziak, D., Mougiakakos, D., Murray, P. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.001 · Cited by 136
Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells
Chen, C., Hsu, S.-C., Chung, T.-Y., Chu, C.-Y., Wang, H.-J., Hsiao, P., Yeh, S.-D., Ann, D. K., Yen, Y., & Kung, H.-J. (2021) · Nature Communications · doi:10.1038/s41467-021-22652-9 · Cited by 128
Self-citationKelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 123
Long, Y., Tsai, W.-B., Wangpaichitr, M., Tsukamoto, T., Savaraj, N., Feun, L. G., & Kuo, M. T. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0302 · Cited by 121 · cited 3×
“By contrast, arginine deprivation of ASS1-low melanoma and sarcoma cells leads to downmodulation of glycolysis pathway with increased glutamine anaplerosis and serine synthesis to sustain the TCA cycle [22,23].”
BackgroundBeddowes, E. J., Spicer, J. F., Chan, P. Y., Khadeir, R. S., García-Corbacho, J., Repana, D., Steele, J. P. C., Schmid, P., Szyszko, T. A., Cook, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.3230 · Cited by 121
López-Rivera, E., Jayaraman, P., Parikh, F. S., Davies, M. A., Ekmekçioglu, S., Izadmehr, S., Milton, D. R., Chipuk, J. E., Grimm, E. A., Estrada, Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0588 · Cited by 118
Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervix
Gupta, N., Prasad, P. D., Ghamande, S. A., Martin, P. M., Herdman, A. V., Martindale, R. G., Podolsky, R. H., Mager, S., Ganapathy, M. E., & Ganapathy, V. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.08.016 · Cited by 115
Roles for Innate Immunity in Combination Immunotherapies
Moynihan, K. D., & Irvine, D. J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1340 · Cited by 114
Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.106 · Cited by 113
Lowman, X. H., Hanse, E. A., Yang, Y., Gabra, M. B. I., Tran, T. Q., Li, H., & Kong, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.037 · Cited by 112
Yau, T. C. C., Cheng, P. N.-M., Chan, P., Chan, W., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., & Poon, R. T. P. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9807-9 · Cited by 109
L-Arginine Stimulates Fibroblast Proliferation through the GPRC6A-ERK1/2 and PI3K/Akt Pathway
Fujiwara, T., Kanazawa, S., Ichibori, R., Tanigawa, T., Magome, T., Shingaki, K., Miyata, S., Tohyama, M., & Hosokawa, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092168 · Cited by 108
Bean, G. R., Kremer, J. C., Prudner, B. C., Schenone, A. D., Yao, J.-C., Schultze, M., Chen, D. Y., Tanas, M. R., Adkins, D. R., Bomalaski, J. S., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.232 · Cited by 108
Arginine: Master and Commander in Innate Immune Responses
Morris, S. M. (2010) · Science Signaling · doi:10.1126/scisignal.3135pe27 · Cited by 106
Werner, A., Koschke, M., Leuchtner, N., Luckner‐Minden, C., Habermeier, A., Rupp, J., Heinrich, C., Conradi, R., Closs, E. I., & Munder, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00864 · Cited by 106
Fultang, L., Vardon, A., Santo, C. D., & Mussai, F. (2016) · International Journal of Cancer · doi:10.1002/ijc.30051 · Cited by 105
Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
Zheng, L., MacKenzie, E. D., Karim, S. A., Hedley, A., Blyth, K., Kalna, G., Watson, D. G., Szlosarek, P., Frezza, C., & Gottlieb, E. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-12 · Cited by 103
GPRC6A: Jack of all metabolism (or master of none)
Pi, M., Nishimoto, S. K., & Quarles, L. D. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.12.006 · Cited by 102
Levenberg, B. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)73793-4 · Cited by 100
Garrido, P., Shalaby, A. M., Walsh, E. M., Keane, N., Webber, M., Keane, M., Sullivan, F. J., Kerin, M. J., Callagy, G. M., Ryan, A. E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19631 · Cited by 100
Babu, E., Bhutia, Y. D., Ramachandran, S., Gnana‐Prakasam, J. P., Prasad, P. D., Thangaraju, M., & Ganapathy, V. (2015) · Biochemical Journal · doi:10.1042/bj20150437 · Cited by 96
Alexandrou, C., Al-Aqbi, S. S., Higgins, J. A., Boyle, W., Karmokar, A., Andreadi, C., Luo, J., Moore, D. A., Viskaduraki, M., Blades, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30591-7 · Cited by 96
Targeting extracellular nutrient dependencies of cancer cells
García‐Bermúdez, J., Williams, R. T., Guarecuco, R., & Birsoy, K. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.011 · Cited by 96
Riess, C., Shokraie, F., Classen, C. F., Kreikemeyer, B., Fiedler, T., Junghanß, C., & Maletzki, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495382 · Cited by 95
Tomlinson, B. K., Thomson, J. A., Bomalaski, J. S., Diaz, M., Akande, T., Mahaffey, N., Li, T., Dutia, M. P., Kelly, K. L., Gong, I.-Y., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2610 · Cited by 90
Immune Evasion by Helicobacter pylori Is Mediated by Induction of Macrophage Arginase II
Lewis, N. D., Asim, M., Barry, D. P., de Sablet, T., Singh, K., Piazuelo, M. B., Gobert, A. P., Chaturvedi, R., & Wilson, K. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003431 · Cited by 88
Lü, Y., Wang, W., Wang, J., Yang, C., Mao, H.-M., Fu, X., Wu, Y., Cai, J., Han, J., Xu, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073866 · Cited by 87
Abdelmagid, S. A., Rickard, J. A., McDonald, W. J. F., Thomas, L. N., & Too, C. K. L. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23022 · Cited by 87
Werner, A., Amann, E., Schnitzius, V., Habermeier, A., Luckner‐Minden, C., Leuchtner, N., Rupp, J., Closs, E. I., & Munder, M. (2015) · European Journal of Immunology · doi:10.1002/eji.201546047 · Cited by 86
Tsai, H., Jiang, S. S., Hung, W.-C., Borthakur, G. M., Lin, S.-F., Pemmaraju, N., Jabbour, E. J., Bomalaski, J. S., Chen, Y., Hsiao, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10542-4 · Cited by 84
GPRC6A regulates prostate cancer progression
Pi, M., & Quarles, L. D. (2011) · The Prostate · doi:10.1002/pros.21442 · Cited by 80
Yau, T. C. C., Cheng, P., Chan, P., Chen, L., Yuen, J. H. F., Pang, R. W. C., Fan, S. T., Wheatley, D. N., & Poon, R. T. P. (2015) · Investigational New Drugs · doi:10.1007/s10637-014-0200-8 · Cited by 79
Lowery, M. A., Yu, K. H., Kelsen, D. P., Harding, J. J., Bomalaski, J. S., Glassman, D. C., Covington, C. M., Brenner, R., Hollywood, E. M., Barba, A., et al. (2017) · Cancer · doi:10.1002/cncr.30897 · Cited by 79
Autophagy: Resetting glutamine-dependent metabolism and oxygen consumption
Lin, T.-C., Chen, Y., Kensicki, E., Li, A. Y. J., Kong, M., Li, Y., Mohney, R. P., Shen, H., Stiles, B. L., Mizushima, N., et al. (2012) · Autophagy · doi:10.4161/auto.21228 · Cited by 78
Self-citationCysteine transporter SLC3A1 promotes breast cancer tumorigenesis
Jiang, Y. Z., Cao, Y., Wang, Y., Li, W., Liu, X., Lv, Y., Li, X., & Mi, J. (2017) · Theranostics · doi:10.7150/thno.18005 · Cited by 77
You, M., Savaraj, N., Kuo, M. T., Wangpaichitr, M., Varona-Santos, J., Wu, C., Nguyen, D. M., & Feun, L. G. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1518-1 · Cited by 75
Cheng, C.-T., Kuo, C., Ouyang, C., Li, C., Chung, Y., Chan, D. C., Kung, H.-J., & Ann, D. K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2921 · Cited by 73
Self-citationPromotion of homology-directed DNA repair by polyamines
Lee, C.-Y., Su, G.-C., Huang, W., Ko, M.-Y., Yeh, H., Chang, G., Lin, S., & Chi, P. (2019) · Nature Communications · doi:10.1038/s41467-018-08011-1 · Cited by 73
Park, S., Lee, S., Song, S., Heo, D., Park, B., Lee, D., Kim, K., & Sung, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11498 · Cited by 72
Hall, P. E., Lewis, R., Syed, N., Shaffer, R. E., Evanson, J., Ellis, S. M., Williams, M., Feng, X., Johnston, A. L., Thomson, J. A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3729 · Cited by 70
Chen, C., Hsieh, F., Cheng, Y.-M., Chang, K., & Lee, P. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20372 · Cited by 68
Self-citationMcAlpine, J. A., Lu, H.-T., Wu, K. C., Knowles, S. K., & Thomson, J. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-621 · Cited by 67
Long, Y., Tsai, W.-B., Chang, J. T., Estecio, M. R., Wangpaichitr, M., Savaraj, N., Feun, L. G., Chen, H. H. W., & Kuo, M. T. (2016) · Oncotarget · doi:10.18632/oncotarget.12308 · Cited by 66
Prudner, B. C., Rathore, R., Robinson, A. M., Godec, A., Chang, S. F., Hawkins, W. G., Hirbe, A. C., & Tine, B. A. V. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0206 · Cited by 66
Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53
Miyamoto, T., Lo, P. H. Y., Saichi, N., Ueda, K., Hirata, M., Tanikawa, C., & Matsuda, K. (2017) · Science Advances · doi:10.1126/sciadv.1603204 · Cited by 65
Santo, C. D., Cheng, P., Beggs, A. D., Egan, S. A., Bessudo, A., & Mussai, F. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0612-6 · Cited by 65
Locke, M., Ghazaly, E. A., Freitas, M. O., Mitsinga, M., Lattanzio, L., Nigro, C. L., Nagano, A., Wang, J., Chelala, C., Szlosarek, P. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.097 · Cited by 62
Brin, E., Wu, K., Lu, H.-T., He, Y., Dai, Z., & He, W. (2017) · Oncotarget · doi:10.18632/oncotarget.19564 · Cited by 61
Yeon, A., You, S., Kim, M., Gupta, A., Park, M. H., Weisenberger, D. J., Liang, G., & Kim, J. (2018) · Theranostics · doi:10.7150/thno.25130 · Cited by 61
Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM
Przystal, J. M., Hajji, N., Khozoie, C., Renziehausen, A., Zeng, Q., Abaitua, F., Hajitou, A., Suwan, K., Want, E. J., Bomalaski, J. S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1195-4 · Cited by 60
Dillon, B. J., Holtsberg, F. W., Ensor, M., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 58
Long, Y., Tsai, W.-B., Wang, D., Hawke, D. H., Savaraj, N., Feun, L. G., Hung, M., Chen, H. H. W., & Kuo, M. T. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.028 · Cited by 54
Werner, A., Pieh, D., Echchannaoui, H., Rupp, J., Rajalingam, K., Theobald, M., Closs, E. I., & Munder, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01268 · Cited by 53
Hsu, S.-C., Chen, C., Cheng, M., Chu, C.-Y., Changou, C. A., Yu, Y., Yeh, S.-D., Kuo, T.-C., Kuo, C.-C., Chuu, C., et al. (2021) · Theranostics · doi:10.7150/thno.54695 · Cited by 52
Self-citationWang, H., Li, Q., Chow, H. Y., Choi, S., & Leung, Y.-C. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-019-00716-1 · Cited by 50
Transport of L-Arginine Related Cardiovascular Risk Markers
Banjarnahor, S. D. S., Rodionov, R. N., König, J., & Maas, R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123975 · Cited by 49
Harding, J. J., Do, R. K., Dika, I. E., Hollywood, E. M., Uhlitskykh, K., Valentino, E., Wan, P., Hamilton, C. R., Feng, X., Johnston, A. L., et al. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3635-3 · Cited by 47
Ji, J. X. Y., Cochrane, D. R., Tessier‐Cloutier, B., Chen, S. Y., Ho, G., Pathak, K. V., Alcazar, I. N., Farnell, D., Leung, S. C. Y., Cheng, A. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1905 · Cited by 45
Kim, S. S., Xu, S., Cui, J., Poddar, S., Le, T. M., Hayrapetyan, H., Li, L., Wu, N., Moore, A. M., Zhou, L., et al. (2019) · Theranostics · doi:10.7150/thno.40195 · Cited by 44
Yao, S., Jankú, F., Subbiah, V., Stewart, J., Patel, S. P., Kaseb, A. O., Westin, S. N., Naing, A., Tsimberidou, A. M., Hong, D. S., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01230-8 · Cited by 44
Arginine deprivation as a new treatment strategy for head and neck cancer
Huang, C., Tsai, S., Kuo, C., Chang, J. S.-M., Jin, Y., Chang, J., & Hsiao, J. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.004 · Cited by 43
Daylami, R., Muilenburg, D. J., Virudachalam, S., & Bold, R. J. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/preaccept-8245834981349245 · Cited by 42
Savaraj, N., Wu, C., Li, Y., Wangpaichitr, M., You, M., Bomalaski, J. S., He, W., Kuo, M. T., & Feun, L. G. (2015) · Oncotarget · doi:10.18632/oncotarget.3370 · Cited by 41
Burrows, N., Cane, G., Robson, M. P., Gaude, E., Howat, W., Szlosarek, P. W., Pedley, R. B., Frezza, C., Ashcroft, M. A., & Maxwell, P. H. (2016) · Scientific Reports · doi:10.1038/srep22950 · Cited by 41
Singh, P. K., Deorukhkar, A., Venkatesulu, B. P., Li, X., Tailor, R. C., Bomalaski, J. S., & Krishnan, S. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0708 · Cited by 41
Noh, E., Kang, S., Shin, Y., Choi, S., Kim, C., Park, I.-S., Wheatley, D. N., & Min, B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20435 · Cited by 40
Hall, P. E., Ready, N., Johnston, A. L., Bomalaski, J. S., Venhaus, R. R., Sheaff, M. T., Krug, L. M., & Szlosarek, P. W. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.07.012 · Cited by 36
Mössner, J., Hammermann, R., & Racké, K. (2001) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0297 · Cited by 35
Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells
Radisavljevic, Z. M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20063 · Cited by 35
Arginine Arms T Cells to Thrive and Survive
Kishton, R. J., Sukumar, M., & Restifo, N. P. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.019 · Cited by 35
Sahu, D., Gupta, S., Hau, A. M., Nakashima, K., Leivo, M. Z., Searles, S. C., Elson, P. J., Bomalaski, J. S., Casteel, D. E., Boss, G. R., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.004 · Cited by 35
Thongkum, A., Wu, C., Li, Y.-Y., Wangpaichitr, M., Navasumrit, P., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Ruchirawat, M., & Savaraj, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061175 · Cited by 35
TSC1/mTOR-controlled metabolic–epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis
Shi, L., Chen, X., Zang, A., Li, T., Hu, Y., Ma, S., Lü, M., Yin, H., Wang, H., Zhang, X., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000420 · Cited by 35
Agrawal, V., Woo, J. H., Mauldin, J., Jo, C., Stone, E. M., Georgiou, G., & Frankel, A. E. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834ae42b · Cited by 34
The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma.
Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Europe PMC (PubMed Central) · Cited by 32
Phase I study of ADI‐PEG20 plus low‐dose cytarabine for the treatment of acute myeloid leukemia
Tsai, H., Hsiao, H., Hsu, Y., Liu, Y., Kao, H., Liu, T., Cho, S., Feng, X., Johnston, A. L., Bomalaski, J. S., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3871 · Cited by 30
The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Drug Target Insights · doi:10.1177/117739280700200016 · Cited by 30
Christiansen, B. C., Wellendorph, P., & Bräuner‐Osborne, H. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706682 · Cited by 27
Wang, M., Basu, A., Palm, T., Hua, J., Youngster, S. K., Hwang, L. A., Liu, H.-C., Li, X., Peng, P., Zhang, Y., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060198y · Cited by 27
Tsai, W.-B., Long, Y., Chang, J. T., Savaraj, N., Feun, L. G., Jung, M., Chen, H. H. W., & Kuo, M. T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11445-0 · Cited by 27
Khalil, N., & Abi‐Habib, R. J. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00883-4 · Cited by 27
Tsai, W.-B., Long, Y., Park, J.-R., Chang, J. T., Liu, H., Rodriguez‐Canales, J., Savaraj, N., Feun, L. G., Davies, M. A., Wistuba, I. I., et al. (2015) · Oncogene · doi:10.1038/onc.2015.237 · Cited by 25
Jiang, H., Guo, S., Xiao, D., Bian, X., Wang, J., Wang, Y., Zhou, H., Cai, J., & Zheng, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.17032 · Cited by 25
Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
Cheon, D., Walts, A. E., Beach, J. A., Lester, J., Bomalaski, J. S., Walsh, C., Wiedemeyer, W. R., Karlan, B. Y., & Oršulić, S. (2014) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.4 · Cited by 23
Kuo, M. T., Long, Y., Tsai, W.-B., Li, Y.-Y., Chen, H. H. W., Feun, L. G., & Savaraj, N. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.12.003 · Cited by 23
Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming
Brashears, C. B., Barlin, M., Ehrhardt, W. R., Rathore, R., Schultze, M., Tzeng, S.-C., Tine, B. A. V., & Held, J. M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02899-8 · Cited by 22
Rogers, L. C., & Tine, B. A. V. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.49 · Cited by 19
Gutiérrez, M. L., Corchete, L. A., Teodósio, C., Sarasquete, M. E., Abad, M., Iglesias, M. J. I., Esteban, C., Sayagués, J. M., Órfão, A., & Muñoz‐Bellvís, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4233 · Cited by 17
Combination of arginine deprivation with TRAIL treatment as a targeted-therapy for mesothelioma.
Wangpaichitr, M., Wu, C., Bigford, G. E., Theodoropoulos, G. E., You, M., Li, Y. Y., Varona-Santos, J., Feun, L. G., Nguyen, D. M., & Savaraj, N. (2014) · PubMed · Cited by 17
Huang, Z., & Hu, H. (2021) · Molecules · doi:10.3390/molecules26020511 · Cited by 17
Exploring the Metabolic Heterogeneity of Cancers: A Benchmark Study of Context-Specific Models
Jalili, M., Scharm, M., Wolkenhauer, O., Damaghi, M., & Salehzadeh‐Yazdi, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060496 · Cited by 16
Roeksomtawin, S., Navasumrit, P., Waraprasit, S., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Savaraj, N., & Ruchirawat, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8807 · Cited by 15
Feng, Q., Bian, X., Liu, X., Wang, Y., Zhou, H., Ma, X., Quan, C., Yao, Y., & Zheng, Z. (2020) · BMC Cancer · doi:10.1186/s12885-020-07133-4 · Cited by 11
Optimizing arginine deprivation for hard-to-treat cancers
Khadeir, R. S., Szyszko, T. A., & Szlosarek, P. W. (2017) · Oncotarget · doi:10.18632/oncotarget.22099 · Cited by 9
Metadata
- Authors
- Chen, C.-L., Hsu, S.-C., Ann, D. K., Yen, Y., & Kung, H.-J.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-07-15
- Volume
- 13
- Issue
- 14
- Pages
- 3541
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3180518876
- Cited by
- 265
- References
- 164
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.